Business Development and Licensing for Pharma

Business Development and Licensing For Pharma

Strategic and tactical support to evaluate in/out licensing opportunities and the commercial potential for pharma assets.
Get In Touch
This is Placeholder Image

Overview

We offer a broad range of services to identify, qualify, and prioritize potential in/out licensing candidates and evaluate the assets' commercial potential. From rapid assessment to comprehensive due diligence engagements, we draw upon our substantial capabilities to deliver information seamlessly within and across the phases of your engagement.

What do you get with Business Development and Licensing For Pharma?

Comprehensive and robust data sources

We have access to a broad range of data, and leverage the correct sources to meet your requirements.

Deep understanding of market characteristics and dynamics

Our vast experience in oncology and rare diseases will help you predict and overcome challenges in your target market.

In-house expertise and efficient operations


Clinical, epidemiology, access, and forecasting experts work collaboratively to ensure confident decision-making.

Our strengths

  • Appraising the landscape, competitive market, and market access
  • Evaluating product clinical utility and commercial value
  • Identifying, validating, and advising on partnering or acquisition opportunities
  • Conducting commercial and scientific due diligence
  • Forecasting revenues, analyzing cash flows, and valuing assets
  • Determining optimal market access strategies





Resources and data

We support our engagements with accurate and reliable data from a range of sources, including CancerMPact®, CancerLandscape®, Epi Database®, and Cerner Real-World Data™ (CRWD). We use a holistic approach, integrating the appropriate experts and data to meet your requirements.

Working with us

Our multidisciplinary structure mirrors that of a typical pharma business development and licensing team, and offers comprehensive resources with subject matter experts in clinical and commercial functions, including market access.

We can support you as part of a long-term strategic process, or with tactical support at critical points in the process, which may include an independent third-party validation.